Therapeutic Area | MeSH |
---|---|
nervous system diseases | D009422 |
signs and symptoms pathological conditions | D013568 |
Tradename | Proper name | Company | Number | Date | Products |
---|---|---|---|---|---|
Myobloc | rimabotulinumtoxinB | Solstice NeuroSciences | N-103846 RX | 2000-12-08 | 3 products |
Expiration | Code | ||
---|---|---|---|
rimabotulinumtoxinb, Myobloc, Solstice NeuroSciences, LLC | |||
2107-12-08 | Orphan excl. |
Code | Description |
---|---|
J0587 | Injection, rimabotulinumtoxinb, 100 units |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Muscle spasticity | D009128 | — | — | 1 | 2 | 2 | 1 | 3 | 7 |
Dystonia | D004421 | — | — | — | 1 | — | 4 | 2 | 7 |
Stroke | D020521 | EFO_0000712 | I63.9 | 1 | 1 | 1 | 2 | 2 | 6 |
Torticollis | D014103 | — | F45.8 | — | 2 | — | 1 | 2 | 5 |
Overactive urinary bladder | D053201 | EFO_1000781 | N32.81 | — | 2 | — | 2 | — | 4 |
Dystonic disorders | D020821 | — | G24 | — | — | — | 2 | 1 | 3 |
Botulism | D001906 | EFO_0005542 | A05.1 | 2 | — | — | 1 | — | 3 |
Wounds and injuries | D014947 | — | T14.8 | — | 1 | 1 | 1 | — | 2 |
Spinal cord injuries | D013119 | EFO_1001919 | — | — | 1 | 1 | 1 | — | 2 |
Brain injuries | D001930 | — | S06.9 | — | 1 | 1 | 1 | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Cerebral palsy | D002547 | — | G80 | 1 | 2 | 1 | — | 5 | 7 |
Migraine disorders | D008881 | EFO_0003821 | G43 | — | 1 | 5 | — | 1 | 6 |
Sialorrhea | D012798 | — | K11.7 | — | 2 | 4 | — | — | 5 |
Skin aging | D015595 | EFO_0005422 | — | — | 2 | 2 | — | — | 4 |
Pain | D010146 | EFO_0003843 | R52 | — | 3 | 1 | — | — | 3 |
Sclerosis | D012598 | — | — | — | 2 | 2 | — | — | 2 |
Multiple sclerosis | D009103 | EFO_0003885 | G35 | — | 1 | 1 | — | — | 1 |
Traumatic brain injuries | D000070642 | — | S06 | — | 1 | 1 | — | — | 1 |
Sinusitis | D012852 | EFO_0007486 | J32 | — | — | 1 | — | — | 1 |
Rhinosinusitis | D000096825 | — | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hyperhidrosis | D006945 | — | — | 1 | 2 | — | — | — | 3 |
Erectile dysfunction | D007172 | EFO_0004234 | F52.21 | 1 | 2 | — | — | — | 2 |
Temporomandibular joint disorders | D013705 | — | M26.6 | 1 | 1 | — | — | — | 2 |
Myalgia | D063806 | — | M79.1 | — | 1 | — | — | 1 | 2 |
Clostridium botulinum | D003014 | NCBITaxon_1491 | — | — | 1 | — | — | — | 1 |
Systemic scleroderma | D012595 | EFO_0000717 | M34 | — | 1 | — | — | — | 1 |
Depression | D003863 | — | F33.9 | — | 1 | — | — | — | 1 |
Prostatic neoplasms | D011471 | — | C61 | — | 1 | — | — | — | 1 |
Lower urinary tract symptoms | D059411 | EFO_0008008 | — | — | 1 | — | — | — | 1 |
Parkinson disease | D010300 | EFO_0002508 | G20 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 2 | — | — | — | — | 2 |
Complex regional pain syndromes | D020918 | EFO_1001998 | — | 1 | — | — | — | 1 | 2 |
Neck pain | D019547 | — | M54.2 | 1 | — | — | — | — | 1 |
Spasm | D013035 | — | M62.83 | 1 | — | — | — | — | 1 |
Paralysis | D010243 | — | — | 1 | — | — | — | — | 1 |
Myofascial pain syndromes | D009209 | EFO_1001054 | — | 1 | — | — | — | — | 1 |
Temporomandibular joint dysfunction syndrome | D013706 | — | — | 1 | — | — | — | — | 1 |
Fibromyalgia | D005356 | EFO_0005687 | M79.1 | 1 | — | — | — | — | 1 |
Syndrome | D013577 | — | — | 1 | — | — | — | — | 1 |
Pelvic floor disorders | D059952 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Bruxism | D002012 | — | F45.8 | — | — | — | — | 3 | 3 |
Facial paralysis | D005158 | — | G51.0 | — | — | — | — | 1 | 1 |
Facies | D019066 | — | — | — | — | — | — | 1 | 1 |
Hidradenitis suppurativa | D017497 | — | L73.2 | — | — | — | — | 1 | 1 |
Optic atrophy | D009896 | — | H47.2 | — | — | — | — | 1 | 1 |
Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 1 | 1 |
Cleft lip | D002971 | EFO_0003959 | Q36 | — | — | — | — | 1 | 1 |
Neuralgia | D009437 | EFO_0009430 | — | — | — | — | — | 1 | 1 |
Chronic pain | D059350 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Rimabotulinumtoxinb |
INN | — |
Description | Botulinum toxin, or botulinum neurotoxin, is a highly potent neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction, thus causing flaccid paralysis. The toxin causes the disease botulism. The toxin is also used commercially for medical and cosmetic purposes.
|
Classification | Neurotoxin |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2108710 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | DB00083 |
UNII ID | — |